Colorectal Cancer Flashcards
Certain genetic mutations have been implicated in predisposing individuals to colorectal cancer, such as what?
Adenomatous polyposis coli (APC)
Hereditary nonpolyposis colorectal cancer (HNPCC)
Risk factors for colorectal cancer
Increasing age
Male
Family history
IBD
Low fibre diet
High processed meat intake
Smoking
Excess alcohol
Approximately 75% of colorectal cancers are sporadic, developing in people with no specific risk factors.
What is Adenomatous polyposis coli (APC)
A tumour suppressor gene, mutation of the APC gene results in growth of adenomatous tissue, such as Familial Adenomatous Polyposis (FAP)
Genetic predisposition to colorectal cancer
What is Hereditary nonpolyposis colorectal cancer (HNPCC)
A DNA mismatch repair gene, mutation to HNPCC leads to defects in DNA repair, such as Lynch syndrome
Common clinical features of colorectal cancer
Change in bowel habit
Rectal bleeding
Weight loss
Abdominal pain
Symptoms of (iron-deficiency) anaemia.
Right-sided colon cancers – clinical features
Abdominal pain
Iron-deficiency anaemia
Palpable mass in right iliac fossa
Often present late
Left-sided colon cancers – clinical features
Left-sided colon cancers
Rectal bleeding
Change in bowel habit
Tenesmus
Palpable mass in left iliac fossa or on PR exam
Which sided colon cancer is tenesmus more typical of?
Left sided
Which sided colon cancer is rectal bleeding more typical of?
Left sided
Which sided colon cancer is more likely to present late?
Right sided
When does NICE guidance recommend that patients should be referred for urgent investigation of suspected bowel cancer?
≥40yrs with unexplained weight loss AND abdominal pain
≥50yrs with unexplained rectal bleeding
≥60yrs with: iron‑deficiency anaemia or change in bowel habit
Positive occult blood screening test
Rectal or abdominal mass
Aged under 50 with rectal bleeding AND any of the following unexplained symptoms:
Abdominal pain
Change in bowel habit
Weight loss
Iron-deficiency anaemia
Upper vs lower GI cancer - weight loss
As opposed to upper GI malignancies, progressive weight loss is usually only present in colorectal cancer cases with associated metastasis (or rarely in sub-acute bowel obstruction)
Main differentials when considering ?colorectal cancer and how they may differ
Inflammatory bowel disease – The average age of onset of inflammatory bowel disease is younger (20-40yrs) than with colorectal cancer and typically presents with diarrhoea containing blood and mucus
Haemorrhoids – Bright red rectal bleeding on the pan or surface of the stool but rarely presents with abdominal discomfort or pain, altered bowel habits, or weight loss
How often is FIT offered and for who?
In England and Wales, screening is offered every 2 years to men and women aged 60-74 years
For most of the UK a faecal immunochemistry test (FIT) is used
Consequence of a positive FIT?
If any of the samples are positive, patients are offered an appointment with a specialist nurse and further investigation via colonoscopy
Investigations in colorectal cancer
Routine bloods: FBCs (may show microcytic anaemia (iron def)), LFTs, clotting
Carcinoembryonic Antigen (CEA) - used to monitor disease progression and should be conducted both pre- and post-treatment, screening for recurrence.
Colonoscopy with biopsy + removal of any polyps seen(CT colonography considered if not suitable) - GOLD STANDARD INITIAL INVESTIGATION
Staging following initial diagnosis: CT scan/MRI rectum/Endo-anal ultrasound
Staging investigations in colorectal cancer?
CT scan (Chest/Abdomen/Pelvis) to look for distant metastases and local invasion
MRI rectum (for rectal cancers only) to assess the depth of invasion and potential need for pre-operative chemotherapy
Endo-anal ultrasound (for early rectal cancers, T1 or T2 only) to assess suitability for trans-anal resection
Biopsy samples being sent for histology will be assessed using TNM staging, histological subtyping, grading, and assessment of lymphatic, perineural, and venous invasion.
Role of biopsy in colorectal cancer
Biopsy samples being sent for histology will be assessed using TNM staging, histological subtyping, grading, and assessment of lymphatic, perineural, and venous invasion.
Increasingly, samples are also routinely being assessed for varying tumour-based markers (including mismatch-repair testing), to aid in the identification of Lynch syndrome and to optimise potential chemotherapy regimes.
Dukes Stage A colorectal cancer
A Confined beneath the muscularis - limited to the bowel wall
Dukes Stage B colorectal cancer
Extension through the muscularis propria - extending through the bowel wall
Dukes Stage C colorectal cancer?
Involvement of regional lymph nodes
Dukes Stage D colorectal cancer?
Distant metastasis
General principles of management in colorectal cancer?
All patients should be discussed with the multidisciplinary team (MDT).
The only definitive curative option is surgery, although chemotherapy and radiotherapy have an important role as neoadjuvant and adjuvant treatments, alongside their role in palliation.
Mainstay of curative management of colorectal cancer?
Surgery is the mainstay of curative management for localised bowel cancer. The general plan in most surgical management plans is suitable regional colectomy, to ensure the removal of the primary tumour with adequate margins and lymphatic drainage, followed either by primary anastomosis or formation of a stoma
When is colorectal cancer managed with right hemicolectomy or extended right hemicolectomy
Caecal tumours or ascending colon tumours
What does a right hemicolectomy involve?
During the procedure the ileocolic, right colic, and right branch of the middle colic vessels (branches of the SMA) are divided and removed with their mesenteries
When is colorectal cancer managed with an extended right hemicolectomy
Transverse colon tumour
What surgical approach may be used to manage a caecal tumour?
Right hemicolectomy
What surgical approach may be used to manage an ascending colon tumour?
Right hemicolectomy